4//SEC Filing
HANNA NABIL 4
Accession 0001236543-03-000002
CIK 0000875045other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 7:01 PM ET
Size
11.8 KB
Accession
0001236543-03-000002
Insider Transaction Report
Form 4
HANNA NABIL
Chief Scientific OfficerOther
Transactions
- Other
Common Stock
2003-03-31$29.09/sh+333$9,686→ 433,601 total - Other
Common Stock
2003-06-30$28.87/sh+34$981→ 433,635 total - Exercise/Conversion
Common Stock
2003-09-18$0.50/sh+15,000$7,500→ 448,635 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2003-09-18−15,000→ 252,068 totalExercise: $0.50From: 1995-03-16Exp: 2004-09-12→ Common Stock (15,000 underlying) - Sale
Common Stock
2003-09-18$37.00/sh−15,000$555,000→ 433,635 total
Footnotes (4)
- [F1]Acquisition of shares under the Employee Stock Purchase Plan in a transaction exempt under SEC Rule 16b-3(c).
- [F2]Represents sale by Nabil Hanna pursuant to a qualified written selling plan under SEC rule 10b5-1.
- [F3]Granted under Issuer's Employee Stock Option Plan, in an exempt transaction under SEC rule 16b-3(d).
- [F4]Option becomes exercisable as to 25% of the optioned shares on 9/13/95 and as to the balance of the shares in 36 equal monthly installments thereafter, subject to acceleration in the event the Issuer was to achieve a designated milestone.
Documents
Issuer
IDEC PHARMACEUTICALS CORP / DE
CIK 0000875045
Entity typeother
Related Parties
1- filerCIK 0001236543
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 7:01 PM ET
- Size
- 11.8 KB